Toxocara canis: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Sources==" to "==References==") |
Neil.m.young (talk | contribs) (Text replacement - "6 mg" to "6mg") |
||
| Line 12: | Line 12: | ||
==Management== | ==Management== | ||
*Diethylcarbamazine | *Diethylcarbamazine 6mg/kg/day divided TID x 7-10 days OR mebendazole 100-200 mg BID x 5 days OR albendazole 400 mg BID x 3-5 days | ||
==Disposition== | ==Disposition== | ||
Revision as of 00:07, 21 July 2016
Background
Clinical Features
- Visceral toxocariasis (visceral larva migrans)
- Larvae travel through liver / lungs / CNS causing fever, cough, enlarged liver, pneumonia
- Ocular toxocariasis (ocular larva migrans)
- Larvae travel to the eye causing inflammation and scarring of retina, usually only one eye, irreversible vision loss
Differential Diagnosis
Workup
Management
- Diethylcarbamazine 6mg/kg/day divided TID x 7-10 days OR mebendazole 100-200 mg BID x 5 days OR albendazole 400 mg BID x 3-5 days